98%
921
2 minutes
20
Background: EAT may play a role in the pathophysiology of HFpEF.
Objectives: This study examined associations between increased epicardial adipose tissue (EAT), functional status and invasive exercise hemodynamics in a large cohort of heart failure (HF) with preserved ejection fraction (HFpEF) patients.
Methods: All patients underwent echocardiography, 6-minute walk distance (MWD) test, Kansas City Cardiomyopathy Questionnaire (KCCQ) and invasive hemodynamic assessment at rest and during ergometry. EAT thickness was measured alongside the right ventricle on echocardiography, expressed in mm and patients were divided according to EAT tertiles.
Results: In total, 566 patients were examined with mean age 72±8 years, 62% women, mean EAT thickness was 6.0±2.4 mm and 11,5% had EAT ≥9mm. With increasing EAT thickness tertiles, 6-MWD and KCCQ overall summary score were significantly lower [320 (247-385) vs. 315 (244-383) vs. 287 (210-364) meters, p=.001; 51 (32-67) vs. 45 (32-63) vs. 41, (26-56), p=.003; respectively], whereas the latter was independent of BMI (p=.004). At rest, invasive hemodynamics were not different across EAT tertiles. At peak exercise, patients in the highest EAT thickness tertile had higher pulmonary capillary wedge pressure (PCWP) and PCWP to right atrial pressure gradient, compared to patients in the first and second EAT thickness tertiles (36±8 vs. 34±8 mmHg, p=.009; 18±7 vs. 16±7 mmHg, p=.002, respectively).
Conclusion: EAT thickness was associated with impaired quality of life, lower 6-MWD and higher left-sided filling pressures at peak exercise. Excess EAT may therefore play an important role in functional status and exercise hemodynamics in patients with HFpEF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacadv.2025.102185 | DOI Listing |
Rev Cardiovasc Med
August 2025
Department M3/Internal Medicine VI, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, 540142 Târgu Mureş, Romania.
Background: Epicardial adipose tissue (EAT) is an indicator of high cardiovascular and metabolic risk. This study aimed to investigate the association between EAT thickness (EATT) and liver fibrosis and steatosis in patients with type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD).
Methods: Patients with T2DM and MASLD underwent a complex evaluation, which included clinical, laboratory, and liver and transthoracic cardiac ultrasound assessments.
Radiologie (Heidelb)
September 2025
Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Adnan Menderes Bulvarı (Vatan Street), 34093, Fatih, Istanbul, Turkey.
Purpose: The aim of this study was to investigate the relationship between temporal muscle thickness (TMT) as well as temporal (TMA) and masseter muscle (MMA) area with nutritional status and sarcopenia in older individuals.
Methods: This was a retrospective cross-sectional study. A total of 275 participants were evaluated to establish comprehensive geriatric assessment guidelines.
JACC Adv
August 2025
University of Groningen, University Medical Centre Groningen, Department of Cardiology, Hanzeplein 1, PO Box 30.001, 9700 RB, Groningen, The Netherlands. Electronic address:
Background: EAT may play a role in the pathophysiology of HFpEF.
Objectives: This study examined associations between increased epicardial adipose tissue (EAT), functional status and invasive exercise hemodynamics in a large cohort of heart failure (HF) with preserved ejection fraction (HFpEF) patients.
Methods: All patients underwent echocardiography, 6-minute walk distance (MWD) test, Kansas City Cardiomyopathy Questionnaire (KCCQ) and invasive hemodynamic assessment at rest and during ergometry.
Cardiovasc Diabetol
August 2025
Centro Malattie Endocrine e Metaboliche, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy.
Background: Cardiovascular (CV) outcome trials have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce CV mortality in type 2 diabetes (T2DM). We previously found that 4 weeks of SGLT2i treatment increased coronary flow reserve (CFR) by 30% and reduced epicardial adipose tissue (EAT) thickness by 19% in T2DM patients with stable coronary artery disease (CAD). However, long-term effects remain unclear.
View Article and Find Full Text PDFNutr Metab Cardiovasc Dis
July 2025
Department of Nutrition, School of Public Health, University of São Paulo, Brazil.
Background And Aims: The EAT-Lancet Commission advocates a global reference diet for human health within planetary boundaries. Although the EAT-Lancet diet has been associated with health outcomes, its association with subclinical atherosclerosis is yet to be explored. Thus, our aim was to address this question.
View Article and Find Full Text PDF